Fingerprint
Dive into the research topics of 'Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-Week results of the GO-RAISE study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-Week results of the GO-RAISE study
Jürgen Braun, Atul Deodhar, Robert D. Inman, Désirée Van Der Heijde, Michael Mack, Stephen Xu, Benjamin Hsu
Research output: Contribution to journal › Article › peer-review
92
Scopus
citations